FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

260111000001105: Neogest 75microgram tablets (Schering Health Care Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16661701000001119 Neogest 75microgram tablets (Schering Health Care Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16661801000001111 Neogest 75microgram tablets (Schering Health Care Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neogest 75microgram tablets (Schering Health Care Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Is a Product containing precisely norgestrel 75 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has active ingredient Norgestrel false Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Is a Neogest true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has specific active ingredient Norgestrel true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Neogest 75microgram tablets (Schering Health Care Ltd) 35 tablet Is pack of False Neogest 75microgram tablets (Schering Health Care Ltd) Inferred relationship Existential restriction modifier
Neogest 75microgram tablets (Schering Health Care Ltd) 35 tablet Has AMP True Neogest 75microgram tablets (Schering Health Care Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start